Marker Therapeutics Inc (MRKR)

[microcapbiotech]

Sometimes, some things just make no sense to me, like the following:
"This contrasts strongly with the experience of CD-19 CAR-Ts, where up to 40% of patients are expected to relapse within 12 months of developing a complete response.”

OK, if 40% of CAR-T RELAPSE blah blah blah, then WHY are we limited to treating patients who have failed CAR-T?
WHY can we treat patients FIRST AND INSTEAD OF CAR-T???
WHY do they have to go through CAR-T first?

If we are better, then we are better, makes no freaking sense.